C12N 2792/00011
Details
C12N2792/00011 (Details) appears on 1 US grants and 2 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 2
- Assignees
- 3
- Inventors
- 9
- Latest grant
- 28 Aug 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2792/00031Uses of virus other than therapeutic or vaccineIndexing code1
- C12N 2792/00021Viruses as suchIndexing code0
- C12N 2792/00022New viral proteins or individual genes, new structural or functional aspects ofIndexing code0
- C12N 2792/00023Virus like particles [vlp]Indexing code0
- C12N 2792/00032Use of virus as therapeutic agent, other than vaccineIndexing code0
- C12N 2792/00033Use of viral protein as therapeutic agent other than vaccineIndexing code0
- C12N 2792/00034Use of virus or viral component as vaccineIndexing code0
- C12N 2792/00041Use of virus, viral particle or viral elements as a vectorIndexing code0
All 14 subgroupsShow fewer
- C12N 2792/00051Methods of production or purification of viral materialIndexing code0
- C12N 2792/00061Methods of inactivation or attenuationIndexing code0
- C12N 2792/00071Demonstrated in vivo effectIndexing code0
- C12N 2792/00088For redistributionIndexing code0
- C12N 2792/10011FuselloviridaeIndexing code0
- C12N 2792/12011GuttaviridaeIndexing code0
Recent patents
Most cited
By later US patents